Journal of Clinical Densitometry
Volume 12, Issue 3 , Pages 306-313 , July 2009

Prevalence of Low Bone Mass in Relation to Estrogen Treatment and Body Composition in Male-to-Female Transsexual Persons

  • Guy T'Sjoen

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Guy T'Sjoen MD, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium.
    • Department of Endocrinology, Ghent University Hospital, Belgium
    • Both the authors contributed equally in the writing of this article.
    • ,
  • Steven Weyers

      Affiliations

    • Department of Gynaecology, Ghent University Hospital, Belgium
    • Both the authors contributed equally in the writing of this article.
    • ,
  • Youri Taes

      Affiliations

    • Department of Endocrinology, Ghent University Hospital, Belgium
    • ,
  • Bruno Lapauw

      Affiliations

    • Department of Endocrinology, Ghent University Hospital, Belgium
    • Unit for Osteoporosis and Metabolic Bone Diseases, Ghent University Hospital, Belgium
    • ,
  • Kaatje Toye

      Affiliations

    • Unit for Osteoporosis and Metabolic Bone Diseases, Ghent University Hospital, Belgium
    • ,
  • S. Goemaere

      Affiliations

    • Unit for Osteoporosis and Metabolic Bone Diseases, Ghent University Hospital, Belgium
    • ,
  • Jean-Marc Kaufman

      Affiliations

    • Department of Endocrinology, Ghent University Hospital, Belgium
    • Unit for Osteoporosis and Metabolic Bone Diseases, Ghent University Hospital, Belgium

Received 26 September 2008 ,Revised 2 November 2008 ,Accepted 5 November 2008.

References 

  1. Gooren LJ, Giltay EJ, Bunck MC. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab. 2008;93(1):19–25
  2. van Kesteren P, Lips P, Gooren LJG, et al. Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. Clin Endocrinol. 1998;48:347–354
  3. Ruetsche AG, Kneubuehl R, Birkhaeuser MH, Lippuner K. Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study. Osteoporos Int. 2005;16:791–798
  4. Lapauw B, Taes Y, Simoens S, et al. 2008. Bone composition, volumetric and areal bone parameters in male-to-female transsexual persons. Bone 2008 Sept 16.
  5. Mueller A, Dittrich R, Binder H, et al. High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone. Eur J Endocrinol. 2005;153:107–113
  6. Dittrich R, Binder H, Cupisti S, et al. Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist. Exp Clin Endocrinol Diabetes. 2005;113:586–592
  7. Lips P, Asscheman H, Uitewaal P, et al. The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals. J Bone Miner Res. 1989;4(5):657–662
  8. van Kesteren P, Lips P, Deville W, et al. The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals. J Clin Endocrinol Metab. 1996;81(6):2227–2232
  9. Haraldsen IR, Haug E, Falch J, et al. Cross-sex pattern of bone mineral density in early onset gender identity disorder. Horm Behav. 2007;52:334–343
  10. Schlatterer K, Auer DP, Yassouridis A, et al. Transsexualism and osteoporosis. Exp Clin Endocrinol Diabetes. 1998;106:365–368
  11. Reutrakul S, Ongphiphadhanakul B, Piaseu N, et al. The effects of estrogen exposure on bone mass in male to female transsexuals. Clin Endocrinol. 1998;49:811–814
  12. De Cuypere G, T'Sjoen GG, Beerten R, et al. Sexual and Physical Health After Sex Reassignment Surgery. Arch Sex Behav. 2005;34:679–690
  13. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36:936–942
  14. Lapauw B, Taes Y, Bogaert V, et al. Serum estradiol is a determinant of volumetric bone mineral density and modulates the impact of physical activity on bone size at the age of peak bone mass; a study in healthy male siblings. J Bone Miner Res, in press.
  15. Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998;8:468–490
  16. Schießl H, Ferretti JL, Tysarczyk-Niemeyer G, Willnecker J. Noninvasive bone strength index as analysed by peripheral quantitative computed tomography. In:  Schönau E editors. Paediatric osteology. Elsevier Science New developments in diagnostics and therapy. Amsterdam: Elsevier Science; 1996;p. 141–145
  17. Szulc P, Claustrat B, Munoz F, et al. Assessment of the role of 17beta-oestradiol in bone metabolism in men: does the assay technique matter? The MINOS study. Clin Endocrinol. 2001;61:447–457
  18. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666–3672
  19. Sosa M, Jódar E, Arbelo E, et al. Bone mass, bone turnover, vitamin D, and estrogen receptor gene polymorphisms in male to female transsexuals: effects of estrogenic treatment on bone metabolism of the male. J Clin Densitom. 2003;6(3):297–304
  20. T'Sjoen GG, Rubens R, De Sutter P, Gooren L. Authors' response: the endocrine care of transsexual people. J Clin Endocrinol Metab. 2004;89:1014–1015
  21. Diamond TH, Higano CS, Smith MR, Guise TA, Singer FR. Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies. Cancer. 2004;100(5):892–899
  22. Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab. 1989;69:523–527
  23. Bachrach LK. Dual energy X-ray absorptiometry (DXA) measurements of bone density and body composition: promise and pitfalls. J Pediatr Endocrinol Metab. 2000;13(Suppl 2):983–988
  24. Elbers JM, Asscheman H, Seidell JC, Gooren LJG. Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am J Physiol. 1999;276:E317–E325
  25. Miller KK, Biller BM, Hier J, et al. Androgens and bone density in women with hypopituitarism. J Clin Endocrinol Metab. 2002;87:2770–2776
  26. Vanderschueren D, Venken K, Ophoff J, et al. Sex steroids and the periosteum—reconsidering the roles of androgens and estrogens in periosteal expansion. J Clin Endocrinol Metab. 2006;91:378–382
  27. Lorentzon M, Mellström D, Haug E, Ohlsson C. Smoking is associated with lower bone mineral density and reduced cortical thickness in young men. J Clin Endocrinol Metab. 2007;92:497–503
  28. Jensen J, Christiansen C, Rødbro P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med. 1985;313:973–975

PII: S1094-6950(08)00501-5

doi: 10.1016/j.jocd.2008.11.002

Journal of Clinical Densitometry
Volume 12, Issue 3 , Pages 306-313 , July 2009

Article Tools

* Image Usage & Resolution